Clinical Impact of Peroral Endoscopic Myotomy for Esophageal Achalasia
Primary Purpose
Esophageal Achalasia
Status
Unknown status
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
POEM
Sponsored by
About this trial
This is an interventional treatment trial for Esophageal Achalasia focused on measuring Peroral endoscopic myotomy, Esophageal Achalasia
Eligibility Criteria
Inclusion Criteria:
- with an Eckardt symptom score ≥ 4
- The diagnosis of achalasia was made on the basis of the absence of peristalsis and on impaired relaxation of the LES on established methods (barium swallow, manometry, esophagogastroduodenoscopy)
- Informed patient consent was obtained
Exclusion Criteria:
- Severe cardiopulmonary disease or other serious disease leading to unacceptable surgical risk
- Pseudoachalasia
- megaesophagus (diameter of > 7 cm)
Sites / Locations
- Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan UniversityRecruiting
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
EA
Arm Description
Patients were eligible for enrollment in the study if they had an Eckardt symptom score ≥ 4. The diagnosis of achalasia was made on the basis of the absence of peristalsis and on impaired relaxation of the LES on established methods (barium swallow, manometry, esophagogastroduodenoscopy (EGD)).
Outcomes
Primary Outcome Measures
Therapeutic success (a reduction in the Eckardt score to ≤3)
Secondary Outcome Measures
Procedure-related adverse events
Lower esophageal sphincter (LES) pressure on manometry
Reflux symptoms and medication use before and after POEM
Full Information
NCT ID
NCT01649843
First Posted
July 12, 2012
Last Updated
July 22, 2012
Sponsor
Shanghai Zhongshan Hospital
1. Study Identification
Unique Protocol Identification Number
NCT01649843
Brief Title
Clinical Impact of Peroral Endoscopic Myotomy for Esophageal Achalasia
Official Title
Clinical Impact of Peroral Endoscopic Myotomy for Esophageal Achalasia
Study Type
Interventional
2. Study Status
Record Verification Date
July 2012
Overall Recruitment Status
Unknown status
Study Start Date
August 2010 (undefined)
Primary Completion Date
December 2012 (Anticipated)
Study Completion Date
December 2014 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Shanghai Zhongshan Hospital
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Achalasia is a rare esophageal motility disorder, which is characterized clinically by symptoms of dysphagia, regurgitation, weight loss and chest pain. These symptoms are primarily caused by incomplete relaxation of a frequently hypertensive lower esophageal sphincter (LES) and to some extent by a lack of peristalsis in the tubular esophagus. Unfortunately, no therapy returns normal esophageal function. Treatment is therefore directed at lowering the LES pressure, with the aim of reducing the functional obstruction to bolus transit at this site. Current treatments can be endoscopic or surgical. Peroral endoscopic myotomy (POEM) has recently been described as a new minimally invasive endoscopic myotomy technique intending a permanent cure from primary achalasia in some centers. The investigators purpose was to further evaluate the efficacy and the feasibility of POEM for patients with achalasia in a prospective larger study.
Detailed Description
Patients were eligible for enrollment in the study if they had an Eckardt symptom score ≥ 4. The diagnosis of achalasia was made on the basis of the absence of peristalsis and on impaired relaxation of the LES on established methods (barium swallow, manometry, esophagogastroduodenoscopy (EGD)). Exclusion criteria were severe cardiopulmonary disease or other serious disease leading to unacceptable surgical risk, pseudoachalasia, and megaesophagus (diameter of > 7 cm).
All patients were scheduled for a follow-up visit at 1 month after POEM for EGD and manometry. Symptoms were assessed 1 month after treatment in the clinic and every 3 months thereafter via telephone questionnaires.
The primary outcome of the study was therapeutic success (a reduction in the Eckardt score to ≤3) at the follow-up assessment. The secondary outcomes included procedure-related adverse events, LES pressure on manometry pre- and post POEM, reflux symptoms and medication use before and after POEM, and procedure-related parameters such as procedure time, hospital stay, and myotomy length.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Esophageal Achalasia
Keywords
Peroral endoscopic myotomy, Esophageal Achalasia
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
450 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
EA
Arm Type
Experimental
Arm Description
Patients were eligible for enrollment in the study if they had an Eckardt symptom score ≥ 4. The diagnosis of achalasia was made on the basis of the absence of peristalsis and on impaired relaxation of the LES on established methods (barium swallow, manometry, esophagogastroduodenoscopy (EGD)).
Intervention Type
Procedure
Intervention Name(s)
POEM
Intervention Description
Peroral endoscopic myotomy (POEM) has recently been described as a new minimally invasive endoscopic myotomy technique intending a permanent cure from primary achalasia in some centers.
Primary Outcome Measure Information:
Title
Therapeutic success (a reduction in the Eckardt score to ≤3)
Time Frame
Symptoms were assessed 1 month after treatment in the clinic and every 3 months thereafter via telephone questionnaires during follow-up, an expected average of 2 years.
Secondary Outcome Measure Information:
Title
Procedure-related adverse events
Time Frame
All patients were scheduled for a follow-up visit at 1 month after POEM for EGD.
Title
Lower esophageal sphincter (LES) pressure on manometry
Time Frame
All patients were scheduled for a follow-up visit at 1 month after POEM for EGD and manometry
Title
Reflux symptoms and medication use before and after POEM
Time Frame
Symptoms were assessed 1 month after treatment in the clinic and every 3 months thereafter via telephone questionnaires during follow-up, an expected average of 2 years.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
6 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
with an Eckardt symptom score ≥ 4
The diagnosis of achalasia was made on the basis of the absence of peristalsis and on impaired relaxation of the LES on established methods (barium swallow, manometry, esophagogastroduodenoscopy)
Informed patient consent was obtained
Exclusion Criteria:
Severe cardiopulmonary disease or other serious disease leading to unacceptable surgical risk
Pseudoachalasia
megaesophagus (diameter of > 7 cm)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Ping-Hong Zhou, MD,PhD
Email
zhou1968@yahoo.cn
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ping-Hong Zhou, MD,PhD
Organizational Affiliation
Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, Shanghai, China
Official's Role
Study Director
Facility Information:
Facility Name
Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University
City
Shanghai
ZIP/Postal Code
200032
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ping-Hong Zhou, MD,PhD
Email
zhou1968@yahoo.cn
First Name & Middle Initial & Last Name & Degree
Ping-Hong Zhou, MD,PhD
12. IPD Sharing Statement
Citations:
PubMed Identifier
21522116
Citation
Eckardt AJ, Eckardt VF. Treatment and surveillance strategies in achalasia: an update. Nat Rev Gastroenterol Hepatol. 2011 Jun;8(6):311-9. doi: 10.1038/nrgastro.2011.68. Epub 2011 Apr 26.
Results Reference
background
PubMed Identifier
20354937
Citation
Inoue H, Minami H, Kobayashi Y, Sato Y, Kaga M, Suzuki M, Satodate H, Odaka N, Itoh H, Kudo S. Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy. 2010 Apr;42(4):265-71. doi: 10.1055/s-0029-1244080. Epub 2010 Mar 30.
Results Reference
result
PubMed Identifier
22068665
Citation
von Renteln D, Inoue H, Minami H, Werner YB, Pace A, Kersten JF, Much CC, Schachschal G, Mann O, Keller J, Fuchs KH, Rosch T. Peroral endoscopic myotomy for the treatment of achalasia: a prospective single center study. Am J Gastroenterol. 2012 Mar;107(3):411-7. doi: 10.1038/ajg.2011.388. Epub 2011 Nov 8.
Results Reference
result
PubMed Identifier
22609984
Citation
Ren Z, Zhong Y, Zhou P, Xu M, Cai M, Li L, Shi Q, Yao L. Perioperative management and treatment for complications during and after peroral endoscopic myotomy (POEM) for esophageal achalasia (EA) (data from 119 cases). Surg Endosc. 2012 Nov;26(11):3267-72. doi: 10.1007/s00464-012-2336-y. Epub 2012 May 19.
Results Reference
result
PubMed Identifier
25492452
Citation
Hu JW, Li QL, Zhou PH, Yao LQ, Xu MD, Zhang YQ, Zhong YS, Chen WF, Ma LL, Qin WZ, Cai MY. Peroral endoscopic myotomy for advanced achalasia with sigmoid-shaped esophagus: long-term outcomes from a prospective, single-center study. Surg Endosc. 2015 Sep;29(9):2841-50. doi: 10.1007/s00464-014-4013-9. Epub 2014 Dec 10.
Results Reference
derived
Learn more about this trial
Clinical Impact of Peroral Endoscopic Myotomy for Esophageal Achalasia
We'll reach out to this number within 24 hrs